Natixis Advisors, LLC’s Eli Lilly & Co Position
Does Natixis Advisors, LLC own Eli Lilly & Co (LLY)? Yes — 780.7K shares worth $718M (+1.00% of its 13F portfolio) as of Q1 2026, up from 728.5K shares the prior filed quarter.
Position Value
$718M
Q1 2026
Shares
780.7K
% of Portfolio
+1.00%
Quarters Held
30
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 780.7K | $718M | +1.00% |
| Q4 2025 | 728.5K | $783M | +1.11% |
| Q3 2025 | 700.7K | $535M | +0.78% |
| Q2 2025 | 632.1K | $493M | +0.78% |
| Q1 2025 | 645.8K | $533M | +0.99% |
| Q4 2024 | 560.9K | $433M | +0.81% |
| Q3 2024 | 530.7K | $470M | +0.92% |
| Q2 2024 | 531.0K | $481M | +1.05% |
| Q1 2024 | 531.7K | $414M | +0.95% |
| Q4 2023 | 507.1K | $296M | +0.78% |
| Q3 2023 | 474.5K | $255M | +0.78% |
| Q2 2023 | 519.2K | $243M | +0.75% |
| Q1 2023 | 493.8K | $170M | +0.58% |
| Q4 2022 | 494.6K | $181M | +0.68% |
| Q3 2022 | 438.1K | $142M | +0.60% |
| Q2 2022 | 424.3K | $138M | +0.60% |
| Q1 2022 | 388.3K | $111M | +0.42% |
| Q4 2021 | 222.8K | $62M | +0.23% |
| Q3 2021 | 188.8K | $44M | +0.18% |
| Q2 2021 | 175.3K | $40M | +0.19% |
| Q1 2021 | 151.9K | $28M | +0.15% |
| Q4 2020 | 130.9K | $22M | +0.13% |
| Q3 2020 | 125.6K | $19M | +0.12% |
| Q2 2020 | 135.8K | $22M | +0.15% |
| Q1 2020 | 124.9K | $17M | +0.14% |
| Q4 2019 | 85.8K | $11M | +0.08% |
| Q3 2019 | 80.6K | $9M | +0.07% |
| Q2 2019 | 70.7K | $8M | +0.06% |
| Q1 2019 | 74.5K | $10M | +0.08% |
| Q4 2018 | 69.6K | $8M | +0.08% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Natixis Advisors, LLC’s full portfolio or all institutional holders of LLY.